Literature DB >> 27560038

Benefits of active middle ear implants in mixed hearing loss: Stapes versus round window.

Jeon Mi Lee1, Jinsei Jung1, In Seok Moon1, Sung Huhn Kim1, Jae Young Choi1.   

Abstract

OBJECTIVES/HYPOTHESIS: We compared the audiologic benefits of active middle ear implants with those of passive middle ear implants with hearing aids in mixed hearing loss, and also compared the outcomes of stapes vibroplasty with those of round window vibroplasty. STUDY
DESIGN: Retrospective chart review.
METHODS: Thirty-four patients with mixed hearing loss due to chronic otitis media were treated with a middle ear implant. Of these, 15 were treated with a passive middle ear implant (conventional ossiculoplasty with a partial ossicular replacement prosthesis), nine with an active middle ear implant coupling to the stapes, and 10 with an active middle ear implant coupling to the round window. Patients underwent pure-tone/free-field audiograms and speech discrimination tests before surgery and 6 months after surgery, and the results of these tests were compared.
RESULTS: The active middle ear implant resulted in better outcomes than the passive middle ear implant with hearing aids at mid to high frequencies (P < .05). Patients who received either a stapes vibroplasty or a round window vibroplasty showed comparable hearing gain except at 8,000 Hz (48.9 dB vs. 31.0 dB, P < .05). Patients who received a stapes vibroplasty showed an improvement even in bone conduction at 1,000 Hz and 2,000 Hz (both P < .05).
CONCLUSIONS: Active middle ear implantation could be a better option than treatment with passive middle ear implants with hearing aids for achieving rehabilitation in patients with mixed hearing loss. Vibroplasty via either oval window or round window stimulation shares similar good results. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1435-1441, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Mixed hearing loss; Vibrant Soundbridge; couplers; middle ear implant; vibroplasty

Mesh:

Year:  2016        PMID: 27560038     DOI: 10.1002/lary.26244

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Modified-Power-Piston: Short-Incudial-Process-Vibroplasty and Simultaneous Stapedotomy in Otosclerosis.

Authors:  Daniel Dejaco; David Riedl; Timo Gottfried; Thomas Rasse; Natalie Fischer; David Prejban; Viktor Koci; Herbert Riechelmann; Joachim Schmutzhard; Thomas Keintzel
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

2.  Modified Power Piston Versus Simultaneous Stapedotomy With Hearing Aids in Otosclerosis: A Follow-Up Study Exploring Speech Recognition, Quality of Life and Usage of Device.

Authors:  Daniel Dejaco; David Riedl; Anna Elisabeth Cassar; Timo Gottfried; Thomas Rasse; Natalie Fischer; Armina Kreuzer-Simonyan; Josef Seebacher; Herbert Riechelmann; Thomas Keintzel; Joachim Schmutzhard
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

3.  Benefits of active middle ear implants over hearing aids in patients with sloping high tone hearing loss: comparison with hearing aids.

Authors:  J M Lee; J H Jeon; I S Moon; J Y Choi
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-06       Impact factor: 2.124

4.  Effects of Vibrant Soundbridge on tinnitus accompanied by sensorineural hearing loss.

Authors:  Jeon Mi Lee; Hyun Jin Lee; In Seok Moon; Jae Young Choi
Journal:  PLoS One       Date:  2020-02-04       Impact factor: 3.240

5.  Results of Active Middle Ear Implantation in Patients With Mixed Hearing Loss After Middle Ear Surgery: A Prospective Multicenter Study (the ROMEO Study).

Authors:  Chan Il Song; Hyong-Ho Cho; Byung Yoon Choi; Jae Young Choi; Jin Woong Choi; Yun-Hoon Choung; Jong Woo Chung; Won-Ho Chung; Sung Hwa Hong; Yehree Kim; Byung Don Lee; Il-Woo Lee; Jong Dae Lee; Jun Ho Lee; Kyu-Yup Lee; Il Joon Moon; In Seok Moon; Seung-Ha Oh; Hong Ju Park; Shi Nae Park; Ji Won Seo
Journal:  Clin Exp Otorhinolaryngol       Date:  2021-04-09       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.